Malaria Clinical Trial
— CBEHPPOfficial title:
Health Impact Evaluation of the "Community-Based Environmental Health Promotion Programme" in Rwanda
Verified date | July 2017 |
Source | Georgetown University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Community Health Clubs to improve local sanitation, hygiene and health conditions have been
implemented in several countries in Africa and Asia with some success. The Ministry of Health
in Rwanda has committed to rolling out a program designed along similar lines, the Community
Based Environmental Health Promotion Program (CBEHPP), in all 15000 villages across Rwanda.
The main objective of the program is to achieve 'zero open defecation' in all villages of
Rwanda, at least 80% hygienic latrine coverage and improvements in a range of health
behaviors such as the use of mosquito nets, hand-washing with soap and the use of household
water treatment.
To evaluate the impact of the program on health, other socio-economic outcomes and community
functioning, a single district has been chosen where 150 communities will be randomized to
receive the intervention immediately or 18 months later. The evaluation is led by US based
Innovation for Poverty Action (IPA) through researchers based at the National University of
Rwanda, Georgetown University, London School of Hygiene and Tropical Medicine and New York
University. The research team will work in close collaboration with the implementing team,
which consists of the Ministry of Health, Rwanda and Africa AHEAD.
The study will span three years, beginning in May 2013, and ending in late 2015.
Status | Completed |
Enrollment | 8718 |
Est. completion date | June 30, 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 5 Years |
Eligibility |
Inclusion Criteria: -All households with children under 5 years in the study communities are eligible for socio-economic and health outcome evaluation. Exclusion Criteria: -All households are eligible to participate in the intervention. However, for the purposes of the study, households with no children under the age of 5 will not be selected for data collection purposes. |
Country | Name | City | State |
---|---|---|---|
Rwanda | IPA Rwanda District Office | Kamembe | Rusizi District |
Rwanda | Innovations for Poverty Action | Kigali |
Lead Sponsor | Collaborator |
---|---|
Georgetown University | Bill and Melinda Gates Foundation, Emory University, Innovations for Poverty Action, London School of Hygiene and Tropical Medicine, National University, Rwanda, New York University |
Rwanda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Diarrhea | The main outcome of the health impact evaluation trial will be 14 day recall self-reported diarrhoea in children under 5 years. | 2 weeks | |
Secondary | Impact of CBEHPP on height-for-age in children under-5 years | Height-for-age data will be collected from all children under 5 years old. Changes in Z-scores for each of these measures between baseline and endline will be compared across the two study arms and the control group. | 2.5 years | |
Secondary | Impact of CBEHPP on weight-for-age in children under-5 years | weight-for-age data will be collected from all children under 5 years old. Changes in Z-scores for each of these measures between baseline and endline will be compared across the two study arms and the control group. | 2.5 years | |
Secondary | Impact of CBEHPP on drinking water quality | Water quality data will be collected at baseline and endline, and at an intermediate visit following implementation of the program. Water quality will be determined testing of drinking water; study households will provide a sample of drinking water for contamination tests. | 2.5 years | |
Secondary | Impact of CBEHPP on incidence of malaria | Self-reported incidence of malaria, will be collected from households. | 2.5 years | |
Secondary | Impact of CBEHPP on individual contribution to public goods game | A public goods game is played with a subset of community members. The researchers examine the impact of the treatment on the level of contributions. | 2.5 years | |
Secondary | Impact of CBEHPP on administratively verified cases of diarrhea | Total counts of child diarrhea cases recorded in catchment area clinics and community health worker records | 2.5 years | |
Secondary | Impact of CBEHPP on administratively verified cases of pneumonia and severe pneunomia | Total counts of child pneumonia cases recorded in catchment area clinics and community health worker records | 2.5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02315690 -
Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland
|
Phase 3 |